10 Tips To Know About ADHD Medication Pregnancy > 자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep adhd medication prescription uk medication during pregnancy and breastfeeding is a challenge for women suffering from the condition. There are few data regarding how does medication for adhd work exposure over the counter adhd medication for adults time may affect the pregnant fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems such as hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge that more high-quality research is needed.

Risk/Benefit Analysis

Pregnant women who can prescribe adhd medication for adults use ADHD medications need to balance the benefits of taking them against the potential risks to the fetus. Physicians do not have the necessary data to make unequivocal recommendations but they can provide information regarding the risks and benefits to help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who took ADHD medications during their early pregnancy did not face an increased risk of fetal heart malformations or major structural birth defects. Researchers used a large population-based case control study to assess the frequency of structural defects that were major in infants born to mothers who were taking stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts reviewed the cases in order to make sure that the classification was correct and to minimize any bias.

However, the researchers' study was not without its flaws. Most important, they were not able to differentiate the effects of the medication from those of the disorder at hand. That limitation makes it difficult to determine whether the small differences observed in the exposed groups are due to medication use or confounding by comorbidities. In addition, the researchers did not look at the long-term outcomes of offspring.

The study did show that babies whose mothers had taken ADHD medication during pregnancy were at a higher risk of being admitted to the neonatal intensive care unit (NICU) than infants who whose mothers did not take any medication or had cut back on their medications prior to or during pregnancy. This increase was due to central nervous system-related disorders and the increased risk for admission was not found to be influenced by the stimulant medications were used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy also had an elevated chance of having a caesarean birth or having a baby born with an low Apgar score (less than 7). These increases appeared to be unrelated to the type of medication taken during pregnancy.

The research suggests that the small risk associated with the use of ADHD medications during early pregnancy may be offset by the greater benefits to both the mother and child of continued treatment for the woman's disorder. Doctors should discuss with their patients about this and try to help them develop coping skills that can lessen the effects of her disorder on her daily functioning and her relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and being treated with medication, the dilemma of whether or not to stop treatment during pregnancy is one that more and more physicians confront. These decisions are often made without clear and authoritative evidence. Instead, doctors have to weigh their own knowledge in conjunction with the experiences of other doctors and the research on the subject.

The issue of potential risks for infants can be extremely difficult. The research on this subject is based on observation rather than controlled studies, and many of the findings are contradictory. Most studies limit their analysis to live births, which may underestimate the severity of teratogenic effects which can cause abortions or terminations of pregnancy. The study that is discussed in the journal club addresses these limitations, by examining both data on live and deceased births.

The conclusion The conclusion: While some studies have shown an association between ADHD medications and the possibility of certain birth defects, others have found no connection and the majority of studies have a neutral or slightly negative impact. As a result, a careful risk/benefit analysis must be conducted in every situation.

It can be difficult, if not impossible, for women suffering from ADHD to stop taking their medication. In a recent article published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of being isolated. Additionally, the loss of medication may affect the ability to perform job-related tasks and drive safely which are essential aspects of daily life for a lot of people with ADHD.

She recommends women who are uncertain about whether to keep or stop medication in light of their pregnancy, consider the possibility of educating friends, family members and colleagues on the condition, its effects on daily functioning, and on the advantages of staying on the current treatment plan. Educating them can also make the woman feel more comfortable when she is struggling with her decision. It is also worth noting that some medications can be absorbed through the placenta therefore, if a patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware that the effects of the drug can be transferred to the infant.

Risk of Birth Defects

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows as do concerns over the impact that these drugs could have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this issue. Researchers used two huge data sets to study over 4.3 million pregnant women and determine if the use of stimulant medications increased birth defects. Although the risk overall is low, the researchers discovered that the first-trimester exposure to ADHD medications was linked to a slightly higher rate of specific heart defects, like ventriculo-septal defects (VSD).

The authors of the study found no association between the use of early medications and other congenital anomalies, such as facial clefting or club foot. The results are consistent with previous studies that have shown an increase, but not significant, in the risk of developing cardiac malformations among women who started taking ADHD medications prior to the time of pregnancy. The risk grew in the latter half of pregnancy, when many women begin to discontinue their medication.

Women who used ADHD medications during the first trimester of their pregnancy were also more likely to undergo caesarean section, low Apgar score following delivery, and a baby that required breathing assistance at birth. However the researchers of the study were not able to eliminate selection bias by restricting the study to women who did not have any other medical issues that could be a contributing factor to these findings.

Researchers hope their research will help doctors when they meet pregnant women. They suggest that although a discussion of the risks and benefits is crucial however, the decision to stop or continue medication must be based on each woman's requirements and the severity of her ADHD symptoms.

The authors caution that, although stopping the medication is an option to look into, it is not recommended due to the high prevalence of depression and other mental problems among women who are pregnant or recently gave birth. Additionally, research suggests that women who stop taking their medication will have a difficult adjustment to life without them once the baby is born.

Nursing

The responsibilities of being a new mom can be overwhelming. Women with ADHD who must work through their symptoms while attending doctor appointments as well as preparing for the arrival of a baby and adjusting to new household routines may face a lot of challenges. Many women choose to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications are absorbed through breast milk in small amounts, so the risk to breastfeeding infant is minimal. However, the rate of medication exposure to the newborn can vary depending on the dosage, frequency it is administered and at what time it is administered. In addition, different medications enter the baby’s system via the gastrointestinal tract, or through breast milk. The impact of these medications on the health of a newborn isn't fully comprehended.

Because of the lack of research, some doctors may be inclined to discontinue stimulant medication during the pregnancy of a woman. This is a difficult decision for the mother, who must weigh the advantages of taking her medication as well as the risk to the foetus. As long as more information is available, GPs can ask pregnant patients whether they have a history of Adhd Medications For Adults With Anxiety (Anotepad.Com) or if they plan to take medication during the perinatal phase.

Many studies have shown that women can continue to take their ADHD medication in a safe manner during pregnancy and breast-feeding. In the end, an increasing number of patients choose to do so and after consulting with their doctor, they have discovered that the benefits of keeping their current medication far outweigh any potential risks.

It is crucial for women suffering from ADHD who are contemplating breastfeeding to seek a specialist psychiatrist's advice prior to becoming pregnant. They should discuss their medication with their prescriber, and the pros and cons for continuing treatment. This includes non-pharmacological methods. Psychoeducation is also required to help pregnant women suffering from ADHD understand their symptoms and the underlying disorder, learn about available treatment options and strengthen existing strategies for managing. This should be a multidisciplinary process together with obstetricians, GPs and psychiatry. The pregnancy counselling should consist of the discussion of a plan for management for both the mother as well as the child, as well as monitoring for signs of deterioration, and the need for adjustments to the medication regimen.